| Adam Cieslinski, OD | |
|
6650 S Westnedge Ave Ste 232, Portage, MI 49024-3503 | |
| (269) 327-2881 | |
| Not Available |
| Full Name | Adam Cieslinski |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 6 Years |
| Location | 6650 S Westnedge Ave Ste 232, Portage, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437617180 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4901005191 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Point Optical Group | 9032491246 | 13 |
News Archive
Citing fierce pushback from hospitals, California lawmakers sidelined a bill Wednesday that would have protected some patients from surprise medical bills by limiting how much hospitals could charge them for emergency care.
Researchers at Cornell University have used ptychography to achieve the highest resolution ever produced in an electron microscope. The team, led by David Muller, Professor of Applied and Engineering Physics, recently reported their findings in the July 19th issue of Nature, outlining their ability to resolve images to a resolution of 0.39 Å.
Enzo Biochem, Inc. (NYSE: ENZ), announced today that it had entered into a Cooperative Research and Development Agreement (CRADA) with the National Eye Institute, part of the National Institute of Health, to conduct a human clinical trial of Optiquel™, Enzo's oral, proprietary therapeutic for chronic autoimmune uveitis.
While the incidence of disease from HIV and hepatitis is increasing in the United States, little is known about their prevalence in patients undergoing surgery. Now, researchers have shown that nearly 40 percent of surgeries at The Johns Hopkins Hospital occur in patients who tested positive for a bloodborne germ.
PharmAthene, Inc., a biodefense company specializing in the development and commercialization of medical countermeasures against biological and chemical threats, and Avecia Biologics Limited, a contract manufacturer of biopharmaceuticals, has announced that the companies have entered into a definitive sale and purchase agreement under which PharmAthene will acquire all of the assets and intellectual property related to Avecia's biodefense vaccines business.
› Verified 8 days ago
| Provider Name | West Point Optical Group |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1831548890 PECOS PAC ID: 9032491246 Enrollment ID: O20170124001437 |
News Archive
Citing fierce pushback from hospitals, California lawmakers sidelined a bill Wednesday that would have protected some patients from surprise medical bills by limiting how much hospitals could charge them for emergency care.
Researchers at Cornell University have used ptychography to achieve the highest resolution ever produced in an electron microscope. The team, led by David Muller, Professor of Applied and Engineering Physics, recently reported their findings in the July 19th issue of Nature, outlining their ability to resolve images to a resolution of 0.39 Å.
Enzo Biochem, Inc. (NYSE: ENZ), announced today that it had entered into a Cooperative Research and Development Agreement (CRADA) with the National Eye Institute, part of the National Institute of Health, to conduct a human clinical trial of Optiquel™, Enzo's oral, proprietary therapeutic for chronic autoimmune uveitis.
While the incidence of disease from HIV and hepatitis is increasing in the United States, little is known about their prevalence in patients undergoing surgery. Now, researchers have shown that nearly 40 percent of surgeries at The Johns Hopkins Hospital occur in patients who tested positive for a bloodborne germ.
PharmAthene, Inc., a biodefense company specializing in the development and commercialization of medical countermeasures against biological and chemical threats, and Avecia Biologics Limited, a contract manufacturer of biopharmaceuticals, has announced that the companies have entered into a definitive sale and purchase agreement under which PharmAthene will acquire all of the assets and intellectual property related to Avecia's biodefense vaccines business.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam Cieslinski, OD 6650 S Westnedge Ave Ste 232, Portage, MI 49024-3503 Ph: (269) 327-2881 | Adam Cieslinski, OD 6650 S Westnedge Ave Ste 232, Portage, MI 49024-3503 Ph: (269) 327-2881 |
News Archive
Citing fierce pushback from hospitals, California lawmakers sidelined a bill Wednesday that would have protected some patients from surprise medical bills by limiting how much hospitals could charge them for emergency care.
Researchers at Cornell University have used ptychography to achieve the highest resolution ever produced in an electron microscope. The team, led by David Muller, Professor of Applied and Engineering Physics, recently reported their findings in the July 19th issue of Nature, outlining their ability to resolve images to a resolution of 0.39 Å.
Enzo Biochem, Inc. (NYSE: ENZ), announced today that it had entered into a Cooperative Research and Development Agreement (CRADA) with the National Eye Institute, part of the National Institute of Health, to conduct a human clinical trial of Optiquel™, Enzo's oral, proprietary therapeutic for chronic autoimmune uveitis.
While the incidence of disease from HIV and hepatitis is increasing in the United States, little is known about their prevalence in patients undergoing surgery. Now, researchers have shown that nearly 40 percent of surgeries at The Johns Hopkins Hospital occur in patients who tested positive for a bloodborne germ.
PharmAthene, Inc., a biodefense company specializing in the development and commercialization of medical countermeasures against biological and chemical threats, and Avecia Biologics Limited, a contract manufacturer of biopharmaceuticals, has announced that the companies have entered into a definitive sale and purchase agreement under which PharmAthene will acquire all of the assets and intellectual property related to Avecia's biodefense vaccines business.
› Verified 8 days ago
Dr. Katie Lynne Sutter, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6101 Newport Rd Ste A, Portage, MI 49002 Phone: 269-382-6500 Fax: 269-382-2286 | |
Mr. David C Mcclintic, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6123 S Westnedge Ave, Portage, MI 49002 Phone: 269-327-7079 Fax: 269-327-7165 | |
Dr. Lynnette Raye Blostica, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3412 W Centre Ave, Portage, MI 49024 Phone: 269-329-5860 Fax: 269-329-5865 | |
David P Williams, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 410 E Centre Ave, Portage, MI 49002 Phone: 269-327-4454 Fax: 269-327-8717 | |
West Point Optical Group Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6650 S Westnedge Ave, Suite 232, Portage, MI 49024 Phone: 269-237-2881 | |
Dr. Steven S. Ellinger, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1612 E. Centre Ave., Portage, MI 49002 Phone: 269-329-1030 Fax: 269-329-0966 | |
Ferris R Standiford, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3412 W Centre Ave, Portage, MI 49024 Phone: 269-329-5870 Fax: 269-329-5865 |